Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Pituitary

Search In Journal Title:

Abbravation: Pituitary

Search In Journal Abbravation:

Publisher

Kluwer Academic Publishers-Plenum Publishers

Search In Publisher:

DOI

10.1007/s00374-013-0880-9

Search In DOI:

ISSN

1573-7403

Search In ISSN:
Search In Title Of Papers:

IGFI assays current assay methodologies and thei

Authors: David R Clemmons
Publish Date: 2007/04/11
Volume: 10, Issue: 2, Pages: 121-128
PDF Link

Abstract

The diagnosis of disorders of growth hormone GH is dependent upon accurate measurement of insulinlike growth factorI IGFI concentrations since serum IGFI assays have been found to be useful as a screening tests for the presence of growth hormone deficiency GHD in children and in both children and adults they have been found very useful in establishing the diagnosis of acromegaly IGFI is also used extensively to monitor the response to GH treatment in children and adults and to monitor the response to treatment in acromegaly Since IGFI is influenced by several other hormones and physiologic factors as well as GH a knowledge of its regulation is essential to understanding how to properly interpret the measurements Several technical criteria are required for successful laboratory estimation of IGFI values These include elimination of interference of IGFIbinding proteins IGFBP utilization of adequate numbers of normal subjects to define the normal ranges and importantly the use of high affinity high specificity antisera that allow precise and reproducible measurements of the biologically active peptide Cross comparisons of various commercial assays show that the results generally are similar when values are in the normal range However the assays have different performance characteristics when concentrations are either above or below the normal range To obtain cross laboratory standardization for values outside the normal range requires utilization of similar highquality reagents and techniques that are reasonably comparable Without this degree of standardization cross comparisons among various reference laboratories are likely to continue to show wide divergence for values that are above or below the 95 confidence interval A future goal should be the development of standard procedures and reagents that eliminate this degree of variability


Keywords:

References


.
Search In Abstract Of Papers:
Other Papers In This Journal:

  1. Erratum to: An endoscopic modification of the simultaneous ‘above and below’ approach to large pituitary adenomas
  2. Somatostatin receptor ligands in the treatment of acromegaly
  3. Incidence of Cushing’s syndrome and Cushing’s disease in commercially-insured patients <65 years old in the United States
  4. Primary hypothyroidism presenting as pseudoacromegaly
  5. Sellar meningiomas: an endocrinologic perspective
  6. Low frequency of cardniac arrhythmias and lack of structural heart disease in medically-naïve acromegaly patients: a prospective study at baseline and after 1 year of somatostatin analogs treatment
  7. Pituitary tumor apoplexy in patients with Cushing’s disease: endocrinologic and visual outcomes after transsphenoidal surgery
  8. A comparison of cabergoline and bromocriptine on the risk of valvular heart disease in patients with prolactinomas
  9. Sellar and clival plasmacytomas: case series of 5 patients with systematic review of 65 published cases
  10. Analysis of GNAS mutations in 60 growth hormone secreting pituitary tumors: correlation with clinical and pathological characteristics and surgical outcome based on highly sensitive GH and IGF-I criteria for remission
  11. Sellar plasmacytomas: a concise review
  12. Increased clinical symptoms of acromegalic arthropathy in patients with long-term disease control: a prospective follow-up study
  13. Two cases of Kallmann syndrome associated with empty sella
  14. Multiple head and neck tumors following treatment for craniopharyngioma
  15. Modulation of VEGF/Flk-1 receptor expression in the rat pituitary GH3 cell line by growth factors
  16. Acromegalic gigantism, physicians and body snatching. Past or present?
  17. Effectiveness of self- or partner-administration of an extended-release aqueous-gel formulation of lanreotide in lanreotide-naïve patients with acromegaly
  18. Adipsic diabetes insipidus in adult patients
  19. Pituitary gland and β-catenin signaling: from ontogeny to oncogenesis
  20. Differential diagnosis of ACTH-dependent hypercortisolism: imaging versus laboratory
  21. A novel variation in the AVP gene resulting in familial neurohypophyseal diabetes insipidus in a large Italian kindred

Search Result: